Article Details

EC Grants Marketing Authorization to Celltrion Biosimilar for Arthritis Treatment

Retrieved on: 2025-02-26 16:30:54

Tags for this article:

Click the tags to see associated articles and topics

EC Grants Marketing Authorization to Celltrion Biosimilar for Arthritis Treatment. View article details on hiswai:

Excerpt

Avtozma references Roche's tocilizumab offering and has also shown promise as a treatment for CAR-T cell-induced cytokine release syndrome as well ...

Article found on: www.biopharminternational.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up